Researchers describe the symptom profiles of respiratory viral infections.
Jazz Pharma’s Enrylaze wins European approval for AML and LBL – Pharmaceutical Technology
A 3D illustration showing abundant lymphoblasts in blood. Enrylaze, sold as RylaZe in the US and Canada, was approved by the US Food and Drug